| [1] |
McCole DF.IBD candidate genes and intestinal barrier regulation[J]. Inflamm Bowel Dis, 2014, 20(10): 1829-1849.
|
| [2] |
Di Gesualdo F,Capaccioli S,Lulli M. A pathophysiological view of the long non-coding RNA world[J]. Oncotarget, 2014, 5(22): 10976-10996.
|
| [3] |
Franchi L,Warner N,Viani K, et al.Function of Nod-like receptors in microbial recognition and host defense[J]. Immunol Rev, 2009, 227(1): 106-128.
|
| [4] |
Lee J,Park EJ,Kiyono H. MicroRNA-orchestrated pathophysiologic control in gut homeostasis and inflammation[J]. BMB Rep, 2016, 49(5): 263-269.
|
| [5] |
Ghorpade DS,Sinha AY,Holla S, et al.NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inammatory responses in murine model of inammatory bowel disease[J]. J Biol Chem, 2013, 288(46): 33037-33048.
|
| [6] |
Polytarchou C,Hommes DW,Palumbo T, et al.MicroRNA214 is associated with progression of ulcerative colitis and inhibition reduces development of colitis and colitis associated cancer in mice[J]. Gastroenterology, 2015, 149(4): 981-992.
|
| [7] |
Wu W,He Y,Feng X, et al.MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor[J]. Oncotarget, 2017, 8(1): 705-721.
|
| [8] |
Muljo SA,Ansel KM,Kanellopoulou C, et al.Aberrant T cell differentiation in the absence of Dicer[J]. J Exp Med, 2005, 202(2): 261-269.
|
| [9] |
Li G,Yu M,Lee WW, et al.Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity[J]. Nat Med, 2012, 18(10): 1518-1524.
|
| [10] |
Jiang S,Li C,Olive V, et al.Molecular dissection of the miR-17-92 cluster′s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation[J]. Blood, 2011, 118(20): 5487-5497.
|
| [11] |
Kalla R,Ventham NT,Kennedy NA, et al.MicroRNAs：new players in IBD[J]. Gut, 2015, 64(3): 504-517.
|
| [12] |
Escobar TM,Kanellopoulou C,Kugler DG, et al.MiR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression[J]. Immunity, 2014, 40(6): 865-879.
|
| [13] |
Lu C,Chen J,Xu HG, et al.MiR106b and miR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy[J]. Gastroenterology, 2014, 146(1): 188-199.
|
| [14] |
Li JA,Wang YD,Wang K, et al.Down-regulation of miR-214-3p may contribute to pathogenesis of ulcerative colitis via targeting STAT6[J]. Biomed Res Int, 2017, 2017(2): 8524972.
|
| [15] |
Koukos G,Polytarchou C,Kaplan JL, et al.MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis[J]. Gastroenterology, 2013, 145(4): 842-852.
|
| [16] |
Caruso R,Warner N,Inohara N, et al.NOD1 and NOD2：signaling, host defense, and inflammatory disease[J]. Immunity, 2014, 41(6): 898-908.
|
| [17] |
Zidar N,Boštjancˇicˇ E,Jerala M, et al.Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases-hallmark of epithelial-mesenchymal transition[J]. J Cell Mol Med, 2016, 20(10): 1813-1820.
|
| [18] |
Ranjha R,Meena NK,Singh A, et al.Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs[J]. PLoS One, 2017, 12(3): e0173447.
|
| [19] |
Wu F,Zhang S,Dassopoulos T, et al.Identification of microRNAs associated with ileal and colonic Crohn’s disease[J]. Inflamm Bowel Dis, 2010, 16(10): 1729-1738.
|
| [20] |
Paraskevi A,Theodoropoulos G,Papaconstantinou I, et al.Circulating MicroRNA in inammatory bowel disease[J]. J Crohns Colitis, 2012, 6(9): 900-904.
|
| [21] |
Iborra M,Bernuzzi F,Correale C, et al.Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease[J]. Clin Exp Immunol, 2013, 173(2): 250-258.
|
| [22] |
Krissansen GW,Yang Y,Me Queen FM, et al.Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inammatory bowel disease[J]. Inamm Bowel Dis, 2015, 21(3): 520-530.
|
| [23] |
Soubières AA,Poullis A. Emerging biomarkers for the diagnosis and monitoring of inammatory bowel diseases[J]. Inamm Bowel Dis, 2016, 22(8): 2016-2022.
|
| [24] |
Xu XM,Zhang HJ.miRNAs as new molecular insights into inflammatory bowel disease：Crucial regulators in autoimmunity and inflammation[J]. World J Gastroenterol, 2016, 22(7): 2206-2218.
|
| [25] |
Rice J,Roberts H,Burton J, et al.Assay reproducibility in clinical studies of plasma miRNA[J]. PLoS One, 2015, 10(4): e0121948.
|
| [26] |
Viennois E,Zhao Y,Han MK, et al.Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans[J]. Sci Rep, 2017, 7(1): 2520.
|